These single-cell transcriptomic analyses further substantiate the mechanistic model by revealing that THOC1 upregulation aligns with heightened SIN3A–HDAC1/2 scaffold activity across patient-derived GBM cells. The gene discussed is THOC1; the disease is glioblastoma.